Background Small cell lung cancer (SCLC) is highly aggressive with limited therapeutic
options and a poor prognosis. Moreover, noninvasive biomarker tools for detecting disease …

Small cell lung cancer (SCLC) is a rapidly progressive malignancy with no improvement in
survival outcome or change in the standard of care over the past thirty years. In this review …

Aim Detection of novel tumor biomarker will aid in diagnosis of early-stage small cell lung
cancer (SCLC). The purpose of this study was to identify novel tumor biomarker in serum …

Background: Small cell lung cancer is an aggressive form of lung cancer with poor
prognosis. Combined serum biomarkers may give us more information and predictive value …

Background Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At
the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is …

Background Interactions between cancer cells and the surrounding microenvironment are
crucial determinants of cancer progression. During this process, bi-directional …

Background Small cell lung cancer (SCLC) has a poor prognosis, and even with localized
(limited) disease, the 5-year survival has only been around 20%. Elevated levels of …

Lung cancer is the number one cause of cancer death; however, no specific serum
biomarker is available till date for detection of early lung cancer. Despite good initial …

Simple Summary Our study centers on refining the diagnosis of small-cell lung cancer
(SCLC), a unique subtype with distinct therapeutic implications compared to other lung …

Background The purpose of this study is to discover potential biomarkers in serum for the
detection of small cell lung cancer (SCLC). Methods 74 serum samples including 30 from …